Diagnostic options · UAE

Leukemia MRD tests in Dubai & UAE

Compare available Leukemia MRD tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

850.00–2,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Leukemia MRD test prices

Showing 1–3 of 3 matching tests.

Leukemia MRD diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-206 AML ETO t(8;21) Gene Rearrangement Quantitative MRD Monitor Test This test quantifies the AML1-ETO fusion transcript to monitor minimal residual disease (MRD) in patients with t(8;21) positive AML.	Bone marrow or 5 mL whole blood (Lavender EDTA)	3 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AML1-ETO (RUNX1-RUNX1T1) fusion transcript levels", "Minimal Residual Disease (MRD)"] Parameters [{"name": "AML1-ETO Fusion Transcript Level", "reference_range": "Undetectable (typically < 10⁻⁴ or 10⁻⁵)"}] Preparation [] Indications ["Monitoring response to therapy in t(8;21) positive AML", "Assessing risk of relapse", "Guiding treatment de-escalation decisions"] Measurement technique Confirm with laboratory Codes LOINC: 35076-3 ICD-10: C92.0 Clinical summary This test quantifies the AML1-ETO fusion transcript to monitor minimal residual disease (MRD) in patients with t(8;21) positive AML.
TEST-2543 Minimal Residual Disease (MRD) Analysis for T-ALL Test This test detects and quantifies residual T-ALL cells in bone marrow and peripheral blood using flow cytometry.	Bone Marrow Aspirate (first pull) and Peripheral Blood – Sodium Heparin Tubes	3 Working Days	2,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Residual leukemic cells", "T-cell lineage markers", "Aberrant antigen expression patterns"] Parameters [] Preparation ["Share complete clinical history", "Provide previous immunophenotype report", "Provide current medication list", "Arrange for sample collection and immediate shipment at room temperature"] Indications ["Monitoring response to induction therapy for T-ALL", "Guiding treatment de-escalation or intensification", "Predicting relapse risk"] Measurement technique Confirm with laboratory Codes LOINC: 100368-6 ICD-10: C91.00, C91.02 Clinical summary This test detects and quantifies residual T-ALL cells in bone marrow and peripheral blood using flow cytometry.
TEST-2702 NPM1 Gene Mutation Quantitative MRD Monitor Test This test quantifies the level of NPM1 gene mutation in a blood sample to detect minimal residual disease (MRD) in AML patients.	Blood (EDTA tube)	Sample Mon/Thu 11am ⇒ Report Wed/Sat	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NPM1 gene mutation levels", "Minimal Residual Disease (MRD)"] Parameters [] Preparation ["No fasting required", "Sample must be collected in a lavender-top EDTA tube", "Sample must be transported refrigerated, never frozen"] Indications ["Monitoring treatment response in NPM1-mutated AML", "Predicting relapse risk in NPM1-mutated AML"] Measurement technique Confirm with laboratory Codes LOINC: 78579-2 ICD-10: C92.0 Clinical summary This test quantifies the level of NPM1 gene mutation in a blood sample to detect minimal residual disease (MRD) in AML patients.

Category overview

Leukemia MRD: overview

Monitoring the success of your cancer treatment requires the highest level of microscopic precision to ensure you remain confidently on the path to long-term remission. Integrated into our elite Hematology and Oncology services, Leukemia MRD (Minimal Residual Disease) testing detects incredibly low levels of remaining cancer cells that standard microscopic tests cannot see. By leveraging highly sensitive molecular and flow cytometry technology, this vital screening provides definitive reassurance or early warning of relapse, safely guiding proactive adjustments to your personalized treatment plan. Trusted for sensitive oncological monitoring across diagnostic labs in the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical accuracy, and prompt, dependable reporting. Protect your hematological recovery—schedule your leukemia MRD testing in UAE, coordinate a secure sample collection, or consult our specialized hematology-oncology professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.